• Inherited Retinal Diseases
  • Retina Technology
  • RVO
  • Geographic Atrophy
  • Uveitis
  • Ophthalmology
  • Retinal Surgery
  • Imaging
  • AMD
  • Diabetic Macular Edema
  • Diabetic Retinopathy

Latest News

BlueRock Therapeutics and Foundation Fighting Blindness collaborate to add new cohort to Uni-Rare study evaluating inherited retinal diseases
BlueRock Therapeutics and Foundation Fighting Blindness collaborate to add new cohort to Uni-Rare study evaluating inherited retinal diseases

March 28th 2024

The new cohort will add patients living with IRDs caused by mutations in multiple genes to the already existing cohort of patients with IRDs caused by single gene mutations.

Opus Genetics completes dosing of the first cohort in Phase 1/2 trial evaluating the subretinal delivery of OPGx-LCA5
Opus Genetics completes dosing of the first cohort in Phase 1/2 trial evaluating the subretinal delivery of OPGx-LCA5

March 27th 2024

Phase Ib/IIa trial of EXN407 eye drops from Exonate demonstrates safety and tolerability
Phase Ib/IIa trial of EXN407 eye drops from Exonate demonstrates safety and tolerability

March 27th 2024

Nanoscope Therapeutics lead candidate MCO-010 meets endpoints in RESTORE trial for retinitis pigmentosa
Nanoscope Therapeutics lead candidate MCO-010 meets endpoints in RESTORE trial for retinitis pigmentosa

March 26th 2024

Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration
Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration

March 26th 2024

Latest Videos
Continuing Medical Education

Latest News

© 2024 MJH Life Sciences

All rights reserved.